Zyprexa :: Multiple pharmacies comparison.

Drugmaker Eli Lilly has spent a decade downplaying serious health risks of Zyprexa, its best-selling medication for schizophrenia and bipolar disorder, according to internal documents obtained by The New York Times. The documents, provided to the newspaper by a lawyer for patients suing the drugmaker, suggest that the company told sales representatives to minimize its own published data, which show that 30% of Zyprexa users gain 22 pound…

Generic Zyprexa Olanzapine is used for:
Treating schizophrenia or bipolar disorder. It may also be used for other conditions as determined by your doctor.
Generic Zyprexa Olanzapine is an atypical antipsychotic. Exactly how it …

Business Editors/Health/Medical Writers
INDIANAPOLIS–(BUSINESS WIRE)–July 15, 2003
First Atypical Approved for Treatment of Bipolar Mania is Now
First Agent to Receive Additional Approval as a Combination Therapy
Eli Lilly and Company announced today that…

Business Editors/Health/Medical Writers
COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–April 1, 2003
Head-to-Head Zyprexa(R) vs. Geodon(R) Study Provides Additional
Evidence That All Antipsychotic…

Date: March 26, 2008

For Release: Immediately

Refer to: (317) 532-7826 - Marni Lemons

Mlemons@lilly.com

(317) 332-7502 - Tarra Ryker

Ryker_tarra@lilly.com

State of Alaska and Eli Lilly and Company Reach

Agreement to Settle Zyprexa Lawsuit

INDIANAPOLIS, IN and ANCHORAGE, AK — Eli Lilly and Company and the State…

New speculation has risen over Zyprexa since a letter from the FDA to the drugmakers was leaked. Apparently in March, the FDA sent a letter to Eli-Lilly telling Lilly that they would delay the approval of their new drug Symbyax, which is used to treat depression. Symbyax was not approved because it is a combination of Zyprexa and Prozac, and more info was needed about the risk of diabetes in the prescribing label.

According to Pharmalot, Lillys proposed prescribing informa…

Resolution Seen as Best Option for Company and Patients Who Rely on Zyprexa
INDIANAPOLIS, Ind., Oct. 7 /PRNewswire-FirstCall/ — Eli Lilly and Company (NYSE:LLY) today announced that it has resolved a multi-state investigation involving 32 states and the District of Columbia (DC) related to the sales, marketing and promotion of its antipsychotic medication Zyprexa(R) (olanzapine).

“We believe all of the parties involved share an interest in putting this dispu…

WHAT IS ZYPREXA?
Over and over again Pharmaceutical companies have tried to provide remedies for the myriad diseases troubling mankind. Much has been done in the area of physiological diseases but the greater progression would in th…

San Francisco plaintiff rights law firm
Hersh & Hersh today announced the creation of a settlement fund for
personal injury lawsuits brought on behalf of people who were prescribed
the Eli Lilly drug Zyprexa and developed diabetes and other related
illnesses. Hersh & Hersh filed the first Zyprexa lawsuit in the United
States and has been pursuing cases for injured Zyprexa users for several
years. Nancy Hersh was one of four plaintiffs’ lawye…

Date: October 5, 2007

For Release: Immediately
Refer to: (317) 433-8990 - Marni Lemons, (317) 532-7826 - mobile

(317) 276-3787 - Tarra Ryker, (317) 332-7502 - mobile

Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels

Indianapolis, IN - Eli Lilly and Company announced today that as a part of
ong…